Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesIndiva Ltd

Indiva Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-09-25T03:34:09.773072Z
Market Cap
19.56M

Momentum Score

…

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
36.01M
Revenue Per Share
0.23
Gross Profit TTM
8.15M
Debt / Equity
-
ROE
-288.64%
Net Debt
18.66M
ROCE
-24.92%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.05M -15.28M -15.42M -11.40M -8.66M
Net income -10.93M -15.01M -15.42M -11.40M -8.53M
Selling general administrative 12.82M 11.50M 7.47M 9.08M 7.35M
Gross profit 8.15M 7.07M -0.87M 0.05M 0.10M
Reconciled depreciation 0.41M 0.49M 0.39M 0.86M 0.41M
Ebit -6.10M -5.55M -8.89M -9.54M -7.65M
Ebitda -6.19M -11.86M -13.29M -10.10M -7.08M
Operating income -6.10M -6.44M -11.53M -10.10M -7.65M
Other operating expenses - - - 0.24M 0.24M
Interest expense 4.45M 2.93M 2.02M 0.44M 1.16M
Tax provision -0.12M -0.27M 0.00M 0.00M -0.13M
Interest income 0.04M 0.22M 0.00M 0.14M 0.11M
Net interest income -4.68M -2.72M -2.02M -0.30M -1.05M
Income tax expense -0.12M -0.27M 0.00M - -0.13M
Total revenue 34.40M 32.47M 14.65M 0.92M 0.06M
Total operating expenses 40.50M 38.91M 26.18M 11.02M 7.71M
Cost of revenue 26.25M 25.40M 15.52M 0.87M -0.04M
Total other income expense net -0.27M -6.12M -1.87M -1.00M 0.05M
Net income from continuing ops -10.93M -15.01M -15.42M -11.40M -8.53M
Net income applicable to common shares -10.93M -15.22M -15.42M -11.40M -8.53M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 37.85M 42.44M 39.17M 38.10M 35.85M
Intangible assets 1.66M 1.87M 2.08M 0.01M 0.35M
Other current assets 0.44M 0.38M 0.29M 0.04M 0.61M
Total liab 35.70M 30.11M 27.95M 18.81M 6.45M
Total stockholder equity 2.15M 12.33M 11.22M 19.29M 29.40M
Other current liab 0.43M 0.05M 5.10M 1.41M 1.02M
Common stock 57.39M 57.23M 42.42M 37.49M 37.28M
Capital stock 57.39M 57.23M 42.42M 37.49M 37.28M
Retained earnings -67.48M -56.55M -41.24M -25.81M -14.42M
Other liab 0.72M 0.73M 0.76M - -
Other assets 1.97M 2.60M 2.17M 3.35M 2.79M
Cash 2.79M 2.48M 0.31M 0.63M 19.57M
Total current liabilities 13.38M 8.89M 24.03M 16.54M 6.45M
Net debt 18.66M 18.45M 11.83M 7.06M -
Short term debt - - - - 4.40M
Short long term debt 0.25M 0.70M 9.70M 6.23M 4.40M
Other stockholder equity 6.23M 5.61M 5.32M 7.22M 6.53M
Property plant equipment 22.54M 22.46M 22.69M 22.47M 9.28M
Total current assets 11.68M 15.51M 12.22M 10.51M 22.07M
Long term investments - 0.00M 0.00M 1.77M 3.31M
Net tangible assets 0.49M 10.16M 9.14M 19.28M 29.05M
Short term investments - - - - 0.00M
Net receivables 4.13M 5.87M 4.73M 0.83M 0.60M
Long term debt 21.20M 20.23M 2.44M 1.46M -
Inventory 4.14M 6.44M 6.57M 8.80M 1.16M
Accounts payable 12.22M 7.83M 7.25M 8.58M 1.89M
Non currrent assets other - - - 27.59M 12.94M
Non current assets total 26.17M 26.93M 26.95M 27.59M 12.94M
Capital lease obligations 0.56M 0.71M 1.36M 0.92M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.03M -1.79M -2.08M -0.89M -1.22M
Change to liabilities 4.45M -1.18M 2.38M 6.94M 0.76M
Total cashflows from investing activities -1.03M -1.79M -2.08M -12.20M -5.10M
Net borrowings -0.22M 6.27M 3.89M 3.20M 3.20M
Total cash from financing activities -0.22M 21.80M 8.75M 3.20M 12.90M
Change to operating activities 0.38M -6.09M -0.18M -0.20M -2.38M
Net income -10.93M -15.22M -15.42M -11.40M -8.53M
Change in cash 0.31M 2.17M -0.32M -18.93M -1.74M
Begin period cash flow 2.48M 0.31M 0.63M 19.57M 21.30M
End period cash flow 2.79M 2.48M 0.31M 0.63M 19.57M
Total cash from operating activities 1.55M -17.84M -6.98M -9.93M -9.54M
Issuance of capital stock 0.00M 15.26M 4.98M - -
Depreciation 0.41M 0.49M 0.39M 0.63M 0.41M
Other cashflows from investing activities 0.04M 0.00M 0.00M -0.16M 0.11M
Dividends paid - - - 0.00M 0.00M
Change to inventory 1.22M -1.53M 0.80M -7.59M -0.97M
Change to account receivables 1.73M -1.15M -4.14M -0.44M -0.44M
Other cashflows from financing activities - - -0.32M -0.75M -2.09M
Change to netincome 3.31M 5.81M 7.31M 1.22M 1.58M
Capital expenditures 1.07M 1.80M 2.32M 12.06M 3.71M
Change in working capital 7.79M -9.95M 0.13M -0.35M -3.19M
Stock based compensation 0.75M 0.53M 0.25M 0.81M -
Other non cash items 1.22M 2.50M 0.71M -0.63M 1.05M
Free cash flow 0.48M -19.64M -9.30M -20.71M -13.53M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.		 0.15
0.87%		 17.30 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.04
2.25%		 1.96 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 -0.03
8.57%		 0.32 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 -0.01
1.61%		 0.30 20.75 - 1.88 1.89 2.85 10.19

Profile*

Indiva Ltd

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

333 Preston Street, Ottawa, ON, Canada, K1S 5N4

888 649 6686

https://www.indiva.com

Name Title Year Born
Mr. Carmine Marotta Co-Founder, Pres, CEO & Director NA
Ms. Jennifer Welsh Chief Financial Officer NA
Mr. Robert William Carse Chief Operating Officer NA
Mr. Dave Paterson Chief Commercial Officer NA
Mr. Pete Young Co-founder NA
Ms. Kate Abernathy VP of Communications NA
Ms. Sherry Kelly Director of Human Resource NA
Mr. Tomasz Borowicz Chief Brand Officer NA
Ms. Leah Thiel Marketing Director NA
Mr. Eric Van Dam Sales Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

LIF
CAD 21.93
+8.08%
CRON
CAD 5.29
+7.30%
CIA
CAD 2.05
+6.77%
THX
CAD 0.97
+5.43%
OGC
CAD 37.98
+5.38%
GIL
CAD 46.87
-22.45%
IFOS
CAD 1.70
-20.56%
ITH
CAD 1.99
-18.65%
KEEL
CAD 2.41
-17.75%
TNZ
CAD 51.05
-17.39%

Equity Sectors*

  • Basic Materials

    -2.08%

  • Communication Services

    +0.74%

  • Consumer Cyclical

    -2.22%

  • Consumer Defensive

    -0.50%

  • Energy

    -2.12%

  • Financial Services

    -1.76%

  • Healthcare

    -1.14%

  • Industrials

    -3.05%

  • Real Estate

    -0.47%

  • Technology

    -3.49%

  • Utilities

    -1.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…